Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pancreatic Neoplasms 35Carcinoma, Non-Small-Cell Lung 27Breast Neoplasms 15Lung Neoplasms 13Neoplasm Metastasis 12Triple Negative Breast Neoplasms 11Neoplasms 10Colorectal Neoplasms 8Squamous Cell Carcinoma of Head and Neck 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Head and Neck Neoplasms 4Carcinoma, Pancreatic Ductal 4Stomach Neoplasms 3Neoplasms by Site 3Gastrointestinal Neoplasms 3Carcinoma 3Adenocarcinoma 3Vaccinia 2Rectal Neoplasms 2Ovarian Neoplasms 2Neoplasms by Histologic Type 2Gallbladder Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Squamous Cell Carcinoma 2Endometrial Neoplasms 2Colonic Neoplasms 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thymoma 1

Interventions

Etoposide 31Carboplatin 30atezolizumab 17durvalumab 16Cisplatin 14Topotecan 11PM 01183 11Specimen Handling 9pembrolizumab 8Magnetic Resonance Spectroscopy 7olaparib 5Radiotherapy 5berzosertib 4anlotinib 4Paclitaxel 4Nivolumab 4Irinotecan 4Drug Therapy 4tremelimumab 3toripalimab 3tislelizumab 3Temozolomide 3Radiosurgery 3Injections 3Docetaxel 3Biopsy 3Bevacizumab 3AMG 757 3sacituzumab govitecan 2monalizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × 130-nm albumin-bound paclitaxel × 90 days × Clear all
NCT07547332 2026-04-23

Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Not yet recruiting
84 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡